from Yahoo Finance https://ift.tt/2YXxVPV
-
LabCorp expands availability of at-home sample collection kit for COVID-19 testing
from Yahoo Finance https://ift.tt/2T1fHcN
-
U.S. FDA declines to review Bristol Myers, bluebird therapy for multiple myeloma
from Yahoo Finance https://ift.tt/2WUgWeC
The Latest
-
China Says Worst of Flooding Still to Come as Situation ‘Severe’
-
Moderna Receives Additional $472 Million from BARDA for COVID-19 Vaccine; Target Price $90
-
‘McRefugees’ lose restaurant shelter as Hong Kong battles third wave of Covid-19 cases
-
AstraZeneca bets up to $6 billion on new Daiichi cancer drug